Search Results - RERO DOC

Consortium of Swiss Academic Libraries

A phase I clinical and pharmacological study evaluating vinflunine in combination with doxorubicin as first line treatment in metastatic breast cancer

Zaman, K. ; Durando, X. ; Baurain, J.-F ; Humblet, Y. ; Mazzeo, F. ; Bostnavaron, M. ; Meheust, N. ; Monnoyer-Favrel, S. ; Machiels, J.-P ; Bauer, J.

In: Breast Cancer Research and Treatment, 2011, vol. 127, no. 3, p. 689-696

Consortium of Swiss Academic Libraries

Nosocomial nontyphoidal salmonellosis after antineoplastic chemotherapy: reactivation of asymptomatic colonization?

Delaloye, J. ; Merlani, G. ; Petignat, C. ; Wenger, A. ; Zaman, K. ; Monnerat, C. ; Matzinger, O. ; Beck Popovic, M. ; Vuichard, P. ; Ketterer, N. ; Tarr, P.

In: European Journal of Clinical Microbiology and Infectious Diseases, 2004, vol. 23, no. 10, p. 751-758

Consortium of Swiss Academic Libraries

Bone mineral density in breast cancer patients treated with adjuvant letrozole, tamoxifen, or sequences of letrozole and tamoxifen in the BIG 1-98 study (SAKK 21/07)

Zaman, K. ; Thürlimann, B. ; Huober, J. ; Schönenberger, A. ; Pagani, O. ; Lüthi, J. ; Simcock, M. ; Giobbie-Hurder, A. ; Berthod, G. ; Genton, C. ; Brauchli, P. ; Aebi, S.

In: Annals of Oncology, 2012, vol. 23, no. 6, p. 1474-1481

Consortium of Swiss Academic Libraries

Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial

Bonnefoi, H. ; Litière, S. ; Piccart, M. ; MacGrogan, G. ; Fumoleau, P. ; Brain, E. ; Petit, T. ; Rouanet, P. ; Jassem, J. ; Moldovan, C. ; Bodmer, A. ; Zaman, K. ; Cufer, T. ; Campone, M. ; Luporsi, E. ; Malmström, P. ; Werutsky, G. ; Bogaerts, J. ; Bergh, J. ; Cameron, D. A.

In: Annals of Oncology, 2014, vol. 25, no. 6, p. 1128-1136

Consortium of Swiss Academic Libraries

Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer

Karlsson, P. ; Sun, Z. ; Braun, D. ; Price, K. N. ; Castiglione-Gertsch, M. ; Rabaglio, M. ; Gelber, R. D. ; Crivellari, D. ; Collins, J. ; Murray, E. ; Zaman, K. ; Colleoni, M. ; Gusterson, B. A. ; Viale, G. ; Regan, M. M. ; Coates, A. S. ; Goldhirsch, A.

In: Annals of Oncology, 2011, vol. 22, no. 10, p. 2216-2226

Consortium of Swiss Academic Libraries

Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00)

Perey, L. ; Paridaens, R. ; Hawle, H. ; Zaman, K. ; Nolé, F. ; Wildiers, H. ; Fiche, M. ; Dietrich, D. ; Clément, P. ; Köberle, D. ; Goldhirsch, A. ; Thürlimann, B.

In: Annals of Oncology, 2006, vol. 18, no. 1, p. 64-69

Consortium of Swiss Academic Libraries

Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer. A multicenter, single-arm phase II trial (SAKK 24/06)

Rochlitz, C. ; Ruhstaller, T. ; Lerch, S. ; Spirig, C. ; Huober, J. ; Suter, T. ; Bühlmann, M. ; Fehr, M. ; Schönenberger, A. ; von Moos, R. ; Winterhalder, R. ; Rauch, D. ; Müller, A. ; Mannhart-Harms, M. ; Herrmann, R. ; Cliffe, B. ; Mayer, M. ; Zaman, K.

In: Annals of Oncology, 2011, vol. 22, no. 1, p. 80-85

Consortium of Swiss Academic Libraries

Assessment of needs, health-related quality of life, and satisfaction with care in breast cancer patients to better target supportive care

Brédart, A. ; Kop, J.-L ; Griesser, A.-C ; Fiszer, C. ; Zaman, K. ; Panes-Ruedin, B. ; Jeanneret, W. ; Delaloye, J.-F ; Zimmers, S. ; Berthet, V. ; Dolbeault, S.

In: Annals of Oncology, 2013, vol. 24, no. 8, p. 2151-2158

Powered by Invenio
/ © Copyright RERO